Dr. DEAN REGIER, PhD, is a Senior Scientist with Cancer Control Research at BC Cancer, and an Associate Professor at the UBC School of Population and Public Health. Over the past 15 years, Dr. Regier’s program of research has examined the economics of access to precision medicine. He serves on BC's Drug Benefit Council, which makes evidence-informed recommendations to the Ministry of Health about the PharmaCare program formulary drug listings.
Dr. Regier has held university positions in Canada, in the US at the University of Washington, and in the UK where he was a Fulford Research Fellow and Senior Health Economist at the University of Oxford.